Myomo, Inc.

NYSE American:MYO

Sector

🏥 Health Care

Industries

🤖 Robotics

🔬 Clinical Trials

🌐 Internet of Things (IoT)

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 100.74 M

Share Price

USD 2.80

Avg Daily Volume

564,261

Change (1 day)

0.00%

Change (1 year)

-19.31%

Change (YTD)

-56.52%

Myomo, Inc. Price to Earnings Ratio (P/E) on June 13, 2025: -17.33

Myomo, Inc. Price to Earnings Ratio (P/E) is -17.33 on June 13, 2025, a 59.23% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Myomo, Inc. 52-week low Price to Earnings Ratio (P/E) is -8.71 on June 13, 2025, which is 49.72% above the current Price to Earnings Ratio (P/E).
Myomo, Inc. 52-week low Price to Earnings Ratio (P/E) is -33.89 on June 13, 2025, which is -95.53% below the current Price to Earnings Ratio (P/E).
Myomo, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is -19.62.

Daily

From:

To:

Zoom:

Key data

Date	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)	Enterprise Value to EBITDA (EV/EBITDA)

NYSE American: MYO

Myomo, Inc.

CEO	Mr. Paul R. Gudonis
IPO Date	June 12, 2017
Location	United States
Headquarters	137 Portland Street
Employees	184
Sector	🏥 Health Care
Industries Robotics 🔬 Clinical Trials 🌐 Internet of Things (IoT) 🩺 Medical Instruments 💻 Telehealth

Description

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.